Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1008 |
---|---|
Product Name | Anti-Human IL17A Recombinant Antibody(Ixekizumab) |
Molecular Name | Ixekizumab |
Alias | Anti-IL17A Recombinant Antibody, Research Grade Ixekizumab |
CAS Number | 1143503-69-8 |
Molecular Weight | 146.16 kDa |
Target | IL17A[Homo sapiens] |
Isotype | IgG4 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | WB, IP, IF, FuncS, FCM, Neut, ELISA |
Buffer | PBS, pH7.5 |
Background | Ixekizumab, sold under the brand name Taltz, is an injectable medication for the treatment of autoimmune diseases. Chemically, it is a form of a humanized monoclonal antibody.[5] The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |